glucose-6-phosphate dehydrogenase

(redirected from G6PD)
Also found in: Medical, Acronyms, Encyclopedia.
Related to G6PD: G6PD deficiency
Translations

glu·cose-6-phos·phate de·hy·dro·gen·ase

n. glucofosfato de deshidrogenasa, enzima presente en el hígado y los riñones necesaria en la conversión de glicerol a glucosa.
References in periodicals archive ?
However, breastfeeding an infant with G6PD deficiency could lead to hemolytic anemia.
Later on he was tested for G6PD enzyme and found deficient in G6PD enzyme.
As anticipated, the cells in these transgenic animals are more resistant to highly toxic artificial oxidative treatments, thus proving that an increase in G6PD really improves antioxidant defences," explains Sandrina NEbrega-Pereira, first author of the study and currently a researcher at the Institute of Molecular Medicine of the University of Lisbon.
When no methylene blue is added, methemoglobin persists; but, incubation of the samples with methylene blue allows stimulation of the pentose phosphate pathway in subjects with normal G6PD levels.
Neonatal hyperbilirubinemia in G6PD deficient heterozygotes.
The possibility of coexistent G6PD deficiency was excluded as the patient was elderly and had no past medical history or family history of the condition.
According to Sachdev, the treatment procedure had to be changed as tests revealed that the patient suffered from G6PD deficiency.
Baseline Clinical evaluation Careful history and physical Examination Laboratory evaluation CBC with differential WBC count and reticulocyte count Serum chemistry including liver function test and renal function tests Urinalysis G6PD level Follow up Clinical Evaluation Careful history and physical Examination Laboratory evaluation Hemolysis: Especially in G6PD-deficient patients; CBC count with differential WBC count and reticulocyte count every 2 wk.
G6PD status was determined using the standard methaemoglobin reduction test.
The etiology of which could not have been clarified by the above mentioned analyses were further investigated for serum levels of G6PD and pyruvate kinase tandem mass spectrometry (MS) and TORCH"; and for urinalysis culture and reducing substances.
Exceptions of this include G6PD and gluthatione synthetase deficiency which are characterized with acute hemolytic attacks.